China Resources Double-Crane Pharmaceutical Co Ltd (600062) — Capital Reinvestment Ratio
China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a Capital Reinvestment Ratio of 0.39x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥487.90 Million) in capital expenditures (CN¥192.28 Million). See free cash flow generation of China Resources Double-Crane Pharmaceuti to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China Resources Double-Crane Pharmaceutical Co Ltd Capital Reinvestment Ratio (1999–2024)
This chart tracks China Resources Double-Crane Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 26 annual periods.
Annual Capital Reinvestment Ratio for China Resources Double-Crane Pharmaceutical Co Ltd (1999–2024)
Year-by-year Capital Reinvestment Ratio for China Resources Double-Crane Pharmaceutical Co Ltd from 1999 to 2024. For live market cap and broader valuation context, see China Resources Double-Crane Pharmaceuti market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | CN¥1.83 Billion | CN¥637.50 Million | ▼ -6.1% |
| 2023 | 0.37x | CN¥1.65 Billion | CN¥614.31 Million | ▼ -5.0% |
| 2022 | 0.39x | CN¥1.34 Billion | CN¥525.53 Million | ▲ +6.8% |
| 2021 | 0.37x | CN¥1.34 Billion | CN¥491.67 Million | ▲ +43.3% |
| 2020 | 0.26x | CN¥1.36 Billion | CN¥348.09 Million | ▲ +52.5% |
| 2019 | 0.17x | CN¥1.44 Billion | CN¥241.65 Million | ▲ +7.8% |
| 2018 | 0.16x | CN¥1.47 Billion | CN¥228.69 Million | ▲ +19.4% |
| 2017 | 0.13x | CN¥1.19 Billion | CN¥154.82 Million | ▼ -8.6% |
| 2016 | 0.14x | CN¥771.25 Million | CN¥110.04 Million | ▼ -40.6% |
| 2015 | 0.24x | CN¥701.35 Million | CN¥168.49 Million | ▲ +21.2% |
| 2014 | 0.20x | CN¥718.38 Million | CN¥142.38 Million | ▼ -50.3% |
| 2013 | 0.40x | CN¥546.24 Million | CN¥217.68 Million | ▼ -28.9% |
| 2012 | 0.56x | CN¥396.05 Million | CN¥221.89 Million | ▼ -15.4% |
| 2011 | 0.66x | CN¥511.53 Million | CN¥338.78 Million | ▼ -8.8% |
| 2010 | 0.73x | CN¥509.67 Million | CN¥370.18 Million | ▼ -12.9% |
| 2009 | 0.83x | CN¥342.01 Million | CN¥285.16 Million | ▼ -10.6% |
| 2008 | 0.93x | CN¥331.71 Million | CN¥309.20 Million | ▲ +61.2% |
| 2007 | 0.58x | CN¥235.46 Million | CN¥136.17 Million | ▲ +2.3% |
| 2006 | 0.57x | CN¥303.71 Million | CN¥171.66 Million | ▼ -37.9% |
| 2005 | 0.91x | CN¥139.78 Million | CN¥127.13 Million | ▲ +109.7% |
| 2004 | 0.43x | CN¥453.72 Million | CN¥196.84 Million | ▼ -82.8% |
| 2003 | 2.52x | CN¥148.94 Million | CN¥375.98 Million | ▲ +40.9% |
| 2002 | 1.79x | CN¥140.63 Million | CN¥251.99 Million | ▲ +43.9% |
| 2001 | 1.25x | CN¥141.01 Million | CN¥175.58 Million | ▲ +147.8% |
| 2000 | 0.50x | CN¥172.81 Million | CN¥86.83 Million | ▼ -5.4% |
| 1999 | 0.53x | CN¥131.54 Million | CN¥69.86 Million | — |